Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fagerlund

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Archives of Biochemistry and Biophysics|April 20, 2006
Effects of proteolysis and reduction on phosphatase and ROS-generating activity of human tartrate-resistant acid phosphataseKatja M Fagerlund, Hannele Ylipahkala, Sari L Tiitinen, et al.
Clinical Rehabilitation|September 1, 2009
Effects of a low-frequency sound wave therapy programme on functional capacity, blood circulation and bone metabolism in frail old men and womenA Zheng, R Sakari, S M Cheng, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|March 1, 1996
Tolerance and efficacy of Omniscan (gadodiamide injection) in MR imaging of the central nervous systemS Ekholm, E Jonsson, L Sandvik, et al.
Journal of the National Cancer Institute|May 18, 2013
Survival benefit with radium-223 dichloride in a mouse model of breast cancer bone metastasisMari I Suominen, Jukka P Rissanen, Rami Käkönen, et al.
Clinical Laboratory|December 23, 2008
Clinical performance of six different serum tartrate-resistant acid phosphatase assays for monitoring alendronate treatmentKatja M Fagerlund, Anthony J Janckila, Hannele Ylipahkala, et al.
International Journal of Molecular Sciences|June 2, 2021
Additive Benefits of Radium-223 Dichloride and Bortezomib Combination in a Systemic Multiple Myeloma Mouse ModelMari I Suominen, Jenni Mäki-Jouppila, Anna Huhtinen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2017
Radium-223 Inhibits Osseous Prostate Cancer Growth by Dual Targeting of Cancer Cells and Bone Microenvironment in Mouse ModelsMari I Suominen, Katja M Fagerlund, Jukka P Rissanen, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Archives of Biochemistry and Biophysics|April 20, 2006
Effects of proteolysis and reduction on phosphatase and ROS-generating activity of human tartrate-resistant acid phosphataseKatja M Fagerlund, Hannele Ylipahkala, Sari L Tiitinen, et al.
Clinical Rehabilitation|September 1, 2009
Effects of a low-frequency sound wave therapy programme on functional capacity, blood circulation and bone metabolism in frail old men and womenA Zheng, R Sakari, S M Cheng, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|March 1, 1996
Tolerance and efficacy of Omniscan (gadodiamide injection) in MR imaging of the central nervous systemS Ekholm, E Jonsson, L Sandvik, et al.
Journal of the National Cancer Institute|May 18, 2013
Survival benefit with radium-223 dichloride in a mouse model of breast cancer bone metastasisMari I Suominen, Jukka P Rissanen, Rami Käkönen, et al.
Clinical Laboratory|December 23, 2008
Clinical performance of six different serum tartrate-resistant acid phosphatase assays for monitoring alendronate treatmentKatja M Fagerlund, Anthony J Janckila, Hannele Ylipahkala, et al.
International Journal of Molecular Sciences|June 2, 2021
Additive Benefits of Radium-223 Dichloride and Bortezomib Combination in a Systemic Multiple Myeloma Mouse ModelMari I Suominen, Jenni Mäki-Jouppila, Anna Huhtinen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2017
Radium-223 Inhibits Osseous Prostate Cancer Growth by Dual Targeting of Cancer Cells and Bone Microenvironment in Mouse ModelsMari I Suominen, Katja M Fagerlund, Jukka P Rissanen, et al.
Pageof 6